Recent Finacing
Recent Raise
First Ascent Biomedical’s platform integrates ex vivo drug testing, DNA/RNA sequencing, and AI tumor-weakness mapping to test hundreds of FDA‑approved drugs and deliver personalized treatment plans within 10 days.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
